As the complexity of patient care increases, so does the prevalence of polypharmacy, defined as the concurrent use of multiple medications by a patient. This phenomenon, while sometimes necessary, poses significant challenges due to potential drug-drug interactions (DDIs).
With the aging population and the rise in chronic diseases, polypharmacy has become commonplace. It is particularly prevalent among the elderly, where it is associated with increased morbidity and mortality, decreased physical and cognitive functioning, and a higher risk of hospitalization.
DDIs occur when the effect of one drug is altered by another. They can lead to decreased therapeutic efficacy or increased toxicity. The risk of DDIs exponentially increases with each additional medication, making polypharmacy a significant concern.
Healthcare professionals can employ several strategies to manage polypharmacy effectively. Regular medication reviews are crucial, focusing on the appropriateness of each drug. Deprescribing, the systematic process of identifying and discontinuing drugs in instances where existing or potential harms outweigh benefits, is also an important tool.
Modern healthcare technology can assist in managing polypharmacy. Electronic health records (EHRs) and clinical decision support systems (CDSS) can flag potential DDIs, aiding clinicians in prescribing decisions. However, these tools' effectiveness depends on their correct and consistent use.
Navigating the complex landscape of polypharmacy and DDIs is a crucial aspect of modern healthcare. Through proactive strategies like regular medication reviews and deprescribing, along with the effective use of technology, healthcare professionals can mitigate the risks associated with polypharmacy, enhancing patient safety and outcomes.
1.
Global warming could be driving up women's cancer risk, find researchers
2.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
3.
Survey shows cancer anxiety has impact well beyond the individual diagnosed
4.
MRI can save rectal cancer patients from surgery, study suggests
5.
Glioma Outcomes Shaped by Subtype More Than Tx Sequence
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Practical Breakthroughs in Oncology Across Clinical Settings
3.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
RNA-Targeting Chimeras in Cancer: Mechanisms, Clinical Advances, and Future Directions
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Cancer Care: From Awareness to Recovery
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation